(RTTNews) - Bicycle Therapeutics plc (BCYC), Monday announced updated topline Phase 1 combination data for zelenectide pevedotin plus pembrolizumab in previously untreated (first-line) cisplatin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback